P08254 (MMP3_HUMAN) Homo sapiens (Human)
Stromelysin-1 UniProtKBInterProSTRINGInteractive Modelling
477 aa; Sequence (Fasta)
It is possible new templates exist for this target since these models were created.
Available Structures
44 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| MMP-3/TIMP-1 COMPLEX |
Heteromer P01033; | 100 | 2×ZN; 3×CA; | |||
| Orientation in Solution of MMP-3 Catalytic Domain and N-TIMP-1 from Residual Dipolar Couplings |
Heteromer P01033; | 100 | ||||
| Complex of tissue inhibitor of metalloproteinases-1 (TIMP-1) mutant (L34G/M66S/E67Y/L133N/S155L) wi… |
Heteromer P01033; | 100 | 3×CA; 2×ZN; 1×CL; 1×TRS; 1×SO4; 1×GOL; 1×ACT; | |||
| Complex of tissue inhibitor of metalloproteinase-1 (TIMP-1) mutant L34G with matrix metalloproteina… |
Heteromer P01033; | 100 | 3×CA; 2×ZN; | |||
| Complex of tissue inhibitor of metalloproteinases-1 (TIMP-1) mutant (L34G/L133P/L151C/G154A) with m… |
Heteromer P01033; | 100 | 3×CA; 2×ZN; | |||
| Complex of tissue inhibitor of metalloproteinases-1 (TIMP-1) mutant (L34G/M66D/T98G/P131S/Q153N) wi… |
Heteromer P01033; | 100 | 3×CA; 2×ZN; | |||
| CRYSTAL STRUCTURE OF FIBROBLAST STROMELYSIN-1: THE C-TRUNCATED HUMAN PROENZYME | homo-2-mer | 100.0 | 4×ZN; 4×CA; | |||
| HUMAN STROMELYSIN-1 CATALYTIC DOMAIN COMPLEXED WITH RO-26-2812 | homo-2-mer | 100 | 4×ZN; 6×CA; 1×TR1; | |||
| CRYSTAL STRUCTURE OF MMP3 COMPLEXED WITH A MODIFIED PROLINE SCAFFOLD BASED INHIBITOR. | homo-2-mer | 100 | 4×ZN; 6×CA; 2×SPC; | |||
| DISCOVERY OF POTENT, ACHIRAL MATRIX METALLOPROTEINASE INHIBITORS | homo-2-mer | 100 | 4×ZN; 6×CA; 1×N25; | |||
| STROMELYSIN-1 | homo-2-mer | 100 | 4×ZN; 6×CA; 1×S27; | |||
| DESIGN AND SYNTHESIS OF CONFORMATIONALLY-CONSTRAINED MMP INHIBITORS | homo-2-mer | 100 | 4×ZN; 6×CA; 1×S80; | |||
| HUMAN STROMELYSIN-1 (E202Q) CATALYTIC DOMAIN COMPLEXED WITH RO-26-2812 | homo-2-mer | 98.8 | 4×ZN; 6×CA; 2×TR1; | |||
| CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN FIBROBLAST STROMELYSIN-1 INHIBITED WITH THE N-CA… | homo-2-mer | 100 | 4×ZN; 6×CA; 2×L04; | |||
| CATALYTIC DOMAIN OF HUMAN STROMELYSIN-1 AT PH 5.5 AND 40OC COMPLEXED WITH INHIBITOR | monomer | 100 | 2×ZN; 1×8MI; | |||
| SOLUTION STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN STROMELYSIN-1 COMPLEXED TO A POTENT NON-PEPTIDI… | monomer | 100 | 2×ZN; 2×CA; 1×HAV; 1×3MP; 1×MSB; | |||
| Stromelysin-1 (MMP-3) complexed to a hydroxamic acid inhibitor | monomer | 100 | 2×ZN; 3×CA; 1×FA4; | |||
| A CARBOXYLIC ACID BASED INHIBITOR IN COMPLEX WITH MMP3 | monomer | 100 | 2×ZN; 3×CA; | |||
| CRYSTAL STRUCTURE OF THE STROMELYSIN CATALYTIC DOMAIN AT 2.0 A RESOLUTION | monomer | 100 | 2×ZN; 3×CA; | |||
| CRYSTAL STRUCTURE OF MMP3 COMPLEXED WITH A PIPERAZINE BASED INHIBITOR. | monomer | 100 | 2×ZN; 3×CA; | |||
| CRYSTAL STRUCTURE OF MMP3 COMPLEXED WITH A HETEROCYCLE-BASED INHIBITOR | monomer | 100 | 2×ZN; 3×CA; | |||
| HETEROCYCLE-BASED MMP INHIBITOR WITH P2'SUBSTITUENTS | monomer | 100.0 | 2×ZN; 3×CA; | |||
| CRYSTAL STRUCTURE OF MMP3 COMPLEXED WITH A THIAZEPINE BASED INHIBITOR. | monomer | 100 | 2×ZN; 3×CA; 1×MM3; | |||
| A CARBOXYLIC ACID BASED INHIBITOR IN COMPLEX WITH MMP3 | monomer | 100.0 | 2×ZN; 3×CA; | |||
| X-RAY STRUCTURE OF HUMAN STROMELYSIN CATALYTIC DOMAIN COMPLEXES WITH NON-PEPTIDE INHIBITORS: IMPLIC… | monomer | 100 | 2×ZN; 3×CA; 1×SO4; 1×DPS; | |||
| X-RAY STRUCTURE OF HUMAN STROMELYSIN CATALYTIC DOMAIN COMPLEXES WITH NON-PEPTIDE INHIBITORS: IMPLIC… | monomer | 100 | 2×ZN; 3×CA; 1×SO4; 1×DPS; | |||
| Structure of MMP3 complexed with NNGH inhibitor. | monomer | 100 | 1×ZN; 3×CA; | |||
| Structure of MMP3 complexed with a platinum-based inhibitor | monomer | 100 | 2×ZN; 3×CA; 1×PT; 1×CL; | |||
| Structure of MMP3 complexed with a platinum-based inhibitor. | monomer | 100 | 2×ZN; 3×CA; 1×PT; | |||
| X-ray Structure of a Novel Matrix Metalloproteinase Inhibitor Complexed to Stromelysin | monomer | 100 | 2×ZN; 3×CA; 1×HQQ; | |||
| CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN FIBROBLAST STROMELYSIN-1 INHIBITED WITH THE N-CA… | monomer | 100 | 2×ZN; 3×CA; 1×8MI; | |||
| STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN FIBROBLAST STROMELYSIN-1 INHIBITED WITH THE THIADIAZOLE … | monomer | 100 | 2×ZN; 3×CA; 1×ATT; | |||
| X-RAY STRUCTURE OF HUMAN STROMELYSIN CATALYTIC DOMAIN COMPLEXED WITH NON-PEPTIDE INHIBITORS: IMPLIC… | monomer | 100 | 2×ZN; 3×CA; 1×SO4; 1×IN7; | |||
| catalytic domain of stromelysin-1 in complex with N-Hydroxy-2-(4-methoxy-N-(pyridine-3-ylmethyl)phe… | monomer | 100.0 | 3×CA; 2×ZN; 1×OHL; 1×SO4; | |||
| catalytic domain of stromelysin-1 in complex with N-Hydroxy-2-(4-methylphenylsulfonamido)acetamide | monomer | 100.0 | 3×CA; 2×ZN; 1×Z79; 1×SO4; | |||
| Stromelysin-1 catalytic domain with hydrophobic inhibitor bound, ph 7.0, 32oc, 20 mm cacl2, 15% ace… | monomer | 100 | 2×ZN; 1×CA; 1×0DS; | |||
| STROMELYSIN-1 CATALYTIC DOMAIN WITH HYDROPHOBIC INHIBITOR BOUND, PH 7.0, 32OC, 20 MM CACL2, 15% ACE… | monomer | 100 | 2×ZN; 1×CA; 1×0DS; | |||
| CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN FIBROBLAST STROMELYSIN-1 INHIBITED WITH THIADIAZ… | monomer | 100 | 3×ZN; 3×CA; 1×IN9; | |||
| CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN FIBROBLAST STROMELYSIN-1 INHIBITED WITH THIADIAZ… | monomer | 100 | 3×ZN; 3×CA; 1×IN8; | |||
| CRYSTAL STRUCTURE OF STROMELYSIN CATALYTIC DOMAIN | monomer | 100 | 2×ZN; 3×CA; | |||
| CRYSTAL STRUCTURE OF STROMELYSIN CATALYTIC DOMAIN | monomer | 100 | 2×ZN; 3×CA; | |||
| Solution structure of matrix metalloproteinase 3 (MMP-3) in the presence of N-isobutyl-N-[4-methoxy… | monomer | 100 | 2×ZN; 2×CA; 1×NGH; | |||
| solution structure of matrix metalloproteinase 3 (MMP-3) in the presence of n-hydroxy-2-[n-(2-hydro… | monomer | 100 | 2×ZN; 2×CA; 1×JT5; | |||
| Solution structure of matrix metalloproteinase 3 (MMP-3) in the presence of 3-4'-cyanobyphenyl-4-yl… | monomer | 100 | 2×ZN; 2×CA; 1×JT6; | |||
2 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 1su3.1.A | monomer | 0.74 | 2×ZN; | 56.16 | ||
| 3ba0.1.A | monomer | 0.70 | 2×ZN; 1×HAE; | 52.89 | ||